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study, treatment of early postpartum suckled
beef cows with CIDR-induced ovulation and
initiated estrous cycles with a normal luteal
lifespan in more cows than treatment with MGA,
and treatment with MGA did not induce ovulation
earlier than control cows.

Summary

Postpartum anestrous interval in beef cows is a
major factor contributing to reproductive failure
during a defined breeding season. Our
objectives were to determine the ability of a
controlled internal drug-releasing device (CIDR),
or melengestrol acetate (MGA) to induce
ovulation and to eliminate short estrous cycles.
Multiparous beef cows (n = 75) were equally
assigned by age, days postpartum, body
condition, and body weight to one of three
treatments: CIDR, MGA, or control. All cows
were fed carrier (2 lbs•cow-1•day-1) with MGA
(0.25 mg/lb) or without MGA for 7 days (day -6
to 0). On day -6, CIDR were inserted and were
removed on d 0.
Estrous behavior was
monitored continuously from day -6 until 29
using HeatWatch electronic mount detectors.
Blood was collected three times weekly from day
-6 to 29. Treatment influenced (P = 0.03) the
percentage of cows that were detected in
standing estrus. Beginning on d 2, more CIDRtreated cows had exhibited standing estrus
compared to control cows, but CIDR- and MGAtreated cows did not differ. The percentage of
CIDR-treated cows that had ovulated was
greater (P < 0.05) than the percentage of MGA-,
or control-treated cows beginning on day 4. The
percentage of cows that exhibited standing
estrus before the first postpartum ovulation
(CIDR = 65%, MGA = 57%, control = 30%) did
not differ (P = 0.09) among treatments. Luteal
lifespan following the first ovulation postpartum
and the percentage of cows with a normal luteal
lifespan (progesterone > 1 ng/mL for ≥ 10 d) was
greater (P < 0.01) in CIDR-treated cows (14.0 ±
0.8 days; 20/20, 100%) compared with MGA(6.2 ± 1.0 days; 3/13, 23%), or control-treated
cows (6.1 ± 0.9 days; 4/17, 24%). In the present

Introduction
The anestrous postpartum interval is a major
contributing factor to cows failing to become
pregnant and calving on a yearly interval. In
addition, a short luteal phase can further delay
the interval from calving to conception and
usually occurs following the first postpartum
ovulation. Treatment with some progestins can
induce ovulation in postpartum anestrous cows,
shortening the anestrous postpartum interval
(Yavas and Walton, 2000; Lucy et al., 2001),
and treatment with some progestins before the
first postpartum ovulation reduced or eliminated
the occurrence of a short luteal phase (Smith et
al., 1987; Zollers et al., 1989). Therefore, many
estrous synchronization protocols have included
progestin treatment; however, all progestins do
not have the same biological response. More
specifically, 46% of anestrous beef cows fed
melengestrol acetate (MGA), an orally active
progestin, before GnRH-induced ovulation had a
normal luteal phase, compared with 100% of
cows exposed to progesterone for the same
time period (Smith et al., 1987). Because
different
progestins
have
been
used
interchangeably in estrous synchronization
protocols, the objectives of the present study
were to determine the ability of progesterone or
MGA to induce ovulation in postpartum
anestrous beef cows, and to determine the
ability of each to decrease or eliminate the
occurrence of a short luteal phase following
ovulation.
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cows exhibiting estrus before an increase in
progesterone and the percentage of cows with a
normal length luteal lifespan (progesterone > 1
ng/mL for ≥ 10 days) were analyzed for and
effect of treatment using categorical data
modeling in SAS (Proc Catmod). To determine
differences in the distribution of the response to
the different treatments, the percentage of
animals detected in standing estrus, and the
percentage
of
animals
with
elevated
progesterone (> 1 ng/mL) were analyzed for an
effect of treatment, day, and treatment by day
interaction using analysis of repeated measures
of categorical data.

Materials and Methods
Experimental Design. Postpartum multiparous
(n = 75) crossbred beef cows at the Fort Keogh
Livestock and Range Research Laboratory were
divided equally into three treatment groups
[MGA (0.5 mg•cow-1•day-1), controlled internal
drug-releasing device (CIDR; 1.9 g of
progesterone; InterAG, Hamilton, NZ), and
control] according to age (range 4 to 11 yr), days
postpartum (range 9 to 45 days), cow body
condition score (1 = emaciated and 9 = obese;
range 4 to 6.5), and post calving body weight
(range 445 to 704 kg). Calves were maintained
with cows at all times and allowed to suckle
without restriction.
Cows that had initiated
estrous cycles before the start of treatment were
removed from the study (MGA = 7; CIDR = 3;
control = 3). In addition, one animal in the MGA
group ovulated during MGA treatment and was
removed from the study, but animals that
exhibited standing estrus but did not ovulate
were left in their respective treatment.

Results and Discussion
There were no significant differences among
treatments in days postpartum, body condition
score, or weight at the initiation of treatment
(Table 1). A greater (P < 0.05) percentage of
CIDR-treated cows had exhibited standing
estrus on day 2 after treatment withdrawal
compared with control-treated cows, but
beginning on day 14 no significant difference
was detected between CIDR- and controltreated cows. There was a tendency (P = 0.07),
from day 4 through 10, for the percentage of
CIDR-treated cows that had exhibited estrus to
be greater than the percentage of MGA-treated
cows that had exhibited estrus. The percentage
of MGA- and control-treated cows that exhibited
standing estrus did not differ on any day of the
experiment.

Cows were fed carrier (wheat middlings pellets,
United Agri Products, Miles City, MT) 2 lbs•cow1
•d-1 with MGA (0.25 mg/lb) or without MGA for
7 days (day -6 through day 0). Controlled
internal
drug-releasing
devices
(1.9
g
progesterone per device) were inserted into the
vagina of cows on the first day of treatment (day
-6) and were removed on day 0. All cows were
individually fitted with estrous detection
transmitters and monitored for estrous behavior
continuously from day -6 until day 29 with the
HeatWatch Estrous Detection System (DDx,
Inc., Denver, CO). Cows were considered to be
in standing estrus when three mounts of 2
seconds or longer in duration were recorded
within a 4-hour period.

Peripubertal beef heifers treated with MGA for 8
days, increased proportion of heifers that
initiated estrous cycles following treatment
withdrawal compared with untreated controls
(Imwalle et al., 1998).
In contrast, when
postpartum anestrous beef cows were treated
with MGA for 14 days only 13% ovulated within
7 days of treatment withdrawal (2/16, Perry et
al., 2002). In the present study, ovulation was
defined as occurring 4 days before circulating
concentrations of progesterone were greater
than 1 ng/mL. The percentage of CIDR-treated
cows that ovulated was greater (P < 0.05) than
the percentage of MGA-, or control-treated cows
that ovulated beginning on day 4 after treatment
withdrawal.
On day 18, the cumulative
percentage of CIDR- and control-treated cows
that had ovulated did not differ (P = 0.08), and
no difference was detected between CIDRtreated cows and MGA- (P = 0.19) treated (P =
0.58) cows on day 22 (Figure 2).
The

Blood samples were collected via puncture of a
tail vessel three times weekly for determination
of concentrations of progesterone. Blood was
allowed to clot, stored a 4°C for 24 hours,
centrifuged at 2000 x g for 30 minutes and
serum collected. Serum was stored at -20°C
untilled assayed for progesterone.
Statistical Analysis.
Luteal lifespan was
analyzed for an effect of treatment by ANOVA
using SAS (proc GLM; SAS Inst. Inc., Cary, NC).
When the F statistic was significant (P < 0.05), a
mean separation was performed using the least
significant difference test. The percentage of
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percentage of cows that ovulated was not
different between control- and MGA-treated
cows on any day of the experiment (Figure 2).

in CIDR-treated cows than in MGA- or controltreated cows (Table 2).
Treatment-induced ovulation was defined as
ovulation occurring within 5 days of treatment
withdrawal (increase in concentration of
progesterone > 1 ng/mL on days 5 to 10) for
CIDR- and MGA-treated cows and all ovulations
in control treated cows. Following treatmentinduced ovulation, a longer luteal lifespan (P <
0.01) was detected in CIDR-treated cows than in
MGA- or control-treated cows (Table 2). The
percentage of cows with a normal (≥ 10 d) luteal
lifespan following treatment-induced ovulation
was greater (P < 0.01) in CIDR-treated cows
than MGA- or control-treated cows. This is
consistent with previous reports in which
treatment of anestrous postpartum beef cows
with 0.5 mg•cow-1•d-1 of MGA for 5 days before
GnRH-induced ovulation resulted in only 46% of
cows having a normal luteal phase, but
treatment with progesterone for 5 days before
GnRH-induced ovulation resulted in 100% of
cows having a normal luteal phase (Smith et al.,
1987). Thus, the normal dose of MGA (0.5
mg•cow-1•d-1) is not adequate to prevent the
earlier secretion of uterine PGF2α following the
first postpartum ovulation.

Differences in the response of early postpartum
anestrous beef cows to different progestins may
be explained by the ability of progestins to
increase LH pulse frequency and cause the
formation of a persistent follicle. When early
postpartum anestrous non-suckled (Williams et
al., 1983) and anestrous suckled (Garcia-Winder
et al., 1986) beef cows were treated with low
doses of a progestin LH pulse frequency
increased compared to non-treated controls. In
addition, exposure of peripubertal heifers to a
low dose of norgestomet increased LH pulse
frequency, stimulated follicular development,
and resulted in formation and ovulation of
persistent follicles (Anderson et al., 1996).
Treatment of peripubertal heifers with MGA (0.5
mg•cow-1•d-1) for 7 days increased LH pulse
frequency following treatment withdrawal
(Imwalle et al., 1998), but feeding MGA (0.5
mg•cow-1•d-1) for 14 days to early postpartum
anestrous beef cows did not result in formation
of persistent follicles (Perry et al., 2002). In
contrast, treatment of early postpartum
anestrous dairy cows with low concentrations of
progesterone (CIDR) resulted in increased LH
pulse frequency compared with untreated
controls (Rhodes et al., 1997).

Implications
The anestrous postpartum period and the
occurrence of short estrous cycles are major
factors in cows not conceiving during a defined
breeding season, and treatment with some
progestins before the breeding season can
successfully induced ovulation and eliminated
the occurrence of short estrous cycles.
However, in the current study MGA was not as
effective at inducing ovulation in early
postpartum anestrous beef cows as CIDR
treatment. In addition, treatment with a CIDR
resulted in a normal luteal lifespan following
ovulation compared with a short luteal phase in
cows treated with MGA. Therefore, not all
progestins are equally effective at inducing
ovulation and eliminating short estrous cycles in
early postpartum anestrous cows.

A more synchronous rise in concentration of
progesterone occurred following treatment in
CIDR-treated cows compared with other
treatments (Figure 3). However, no difference
(P = 0.32) was detected among treatments in
the percentage of cows that exhibited standing
estrus before an increase in progesterone (65%,
57%, and 30% for CIDR, MGA, and control,
respectively).
Progesterone treatment is necessary for
establishment of the normal timing of uterine
PGF2α secretion. In the present study, only
cows that had progesterone > 1 ng/mL were
used to determine luteal lifespan and the
percentage of cows with a normal length luteal
lifespan (progesterone > 1 ng/mL for ≥ 10 days).
Following the first ovulation postpartum, CIDRtreated cows had a longer luteal lifespan than
MGA- or control-treated cows (Table 2), and the
percentage of cows that had a normal length
luteal phase (≥ 10 days) was greater (P < 0.01)
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Table 1. Days postpartum, body condition score, and weight at the initiation of treatment
CIDRa
MGAb
Control
No. of cows
22
17
22
Days postpartum (range)
31 ± 1.7
30 ± 2.0
30 ± 1.5
(12 to 42)
(12 to 45)
(9 to 39)
Body condition score
4.9 ± 0.2
4.9 ± 0.2
4.9 ± 0.2
(range)c
(4 to 6)
(3.5 to 6.5)
(3.5 to 6)
Weight, kg
581 ± 16.4
583 ± 17.3
571 ± 16.4
(range)
(477 to 684)
(475 to 704)
(445 to 692)
a

Controlled internal drug–releasing device.
Melengestrol acetate (0.5 mg MGA•cow-1•d-1).
c
Body Condition Score – scale 1 to 9
b

Table 2. Effect of treatment on luteal lifespan and percentage of cows with a normal luteal lifespan
following their first ovulation postpartum and ovulation within 5 days of treatment withdrawal
First postpartum ovulation
CIDR vs
CIDR vs
MGA vs
MGAb
Controld
CIDRa
MGA
Control
Control
No. of cows
20
13
17
- - - - - - - - P-value - - - - - - - Luteal lifespan, dayse
Cows with normal luteal
lifespan, %f

14.0 ± 0.8

6.2 ± 1.0

6.1 ± 0.9

< 0.01

< 0.01

= 0.98

100

23

24

< 0.01

< 0.01

= 0.97

a

CIDR
No. of cows
Luteal lifespan, daysd

20
14.0 ± 0.8

Ovulation within 5 days of treatment withdrawal
CIDR vs
CIDR vs
MGA vs
MGAb
Controlc
MGA
Control
Control
5
17
- - - - - - - - P-value - - - - - - - 4.4 ± 1.1

6.1 ± 0.9

< 0.01

< 0.01

= 0.29

Cows with normal luteal
100
0
24
< 0.01
< 0.01
= 0.15
lifespan, %e
a
Controlled internal drug–releasing device.
b
Melengestrol acetate (0.5 mg MGA•cow-1•day-1).
c
Control animals
d
Interval from first day of concentrations of progesterone were > 1 ng/mL to day concentrations of
progesterone decreased to < 1 ng/mL.
e
Percentage of animals with a luteal lifespan (i.e., concentrations of progesterone > 1 ng/mL) of 10
days or longer.
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Figure 1. Effect of treatment on cumulative percentage of cows detected in standing estrus by day of
treatment (day 0 = last day of feeding melengestrol acetate [MGA], and day of controlled
internal drug-releasing device [CIDR] removal). Treatment P = 0.03; Day P < 0.01; Treatment
x Day P < 0.01.
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Figure 2. Effect of treatment on the cumulative percent of animals that had ovulated (ovulation is shown
as having occurred 4 days before the first day circulating concentrations of progesterone were
> 1 ng/mL) by day of treatment (day 0 = last day of feeding melengestrol acetate [MGA], and
day of controlled internal drug-releasing device [CIDR] removal). Treatment P < 0.01; Day P <
0.01; Treatment x Day P < 0.01.
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Figure 3. Circulating concentrations of progesterone (collected three times weekly) for cows receiving no
treatment (control), 0.5 mg MGA•cow-1•day-1 (MGA), or controlled internal drug-releasing
device (CIDR; from day –6 to 0). Day 0 = last day of feeding MGA and day of CIDR removal.
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